A new long-term study published in the journal of Diabetes Care revealed that early metabolic patterns in prediabetes can forecast the risk of developing severe complications decades later in individuals at…
Taiwan: A large-scale study from Taiwan has found compelling evidence that exposure to common air pollutants, particularly carbon monoxide (CO) and fine particulate matter (PM2.5), is strongly linked to declining…
New Delhi: Russia's experimental mRNA-based cancer vaccine Enteromix has demonstrated 100% efficacy and safety in clinical trials, raising hopes for a breakthrough in the global fight against cancer. Developed using…
Researchers have determined in a new study that a low BMI (<25 kg/m²) increases the risk of progression to active TB among individuals who are IGRA positive and not on…
The U.S. Food and Drug Administration today approved expanded use of Vonvendi [von Willebrand factor (Recombinant)] for routine preventative (prophylactic) use in adults (age 18 years and older) with all…
China: Microwave ablation (MWA) guided by ultrasound is emerging as a promising treatment for managing hyperthyroidism associated with benign thyroid nodules and papillary thyroid carcinoma (PTC), according to a recent…
Belgium: The European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) have released a 2025 Focused Update to their 2019 Guidelines for the management of dyslipidaemias, introducing crucial…
Canada: Women entering pregnancy with multiple chronic conditions (MCC) face significantly higher risks of severe maternal complications, including morbidity and mortality, according to a large population-based study from Ontario, Canada.…
Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and reduced clinically relevant bleeding in patients who underwent coronary artery bypass grafting (CABG),…
Osaka: Takeda has received approval from the U.S. Food and Drug Administration (FDA) for the supplemental Biologics License Application (sBLA) for VONVENDI [von Willebrand factor (Recombinant)], expanding the indication to include…